Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Biocon"


7 mentions found


Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAccess to healthcare will remain a priority for the US, says Biocon CEOPeter Bains, Group CEO of Biocon, talks about how the India-based pharmaceutical company is placed ahead of a second Trump presidency, as well as the development of its weight-loss and anti-obesity drug.
Persons: Peter Bains Organizations: Biocon, Trump Locations: India
CEO of India's Biocon discusses first-quarter results
  + stars: | 2024-08-12 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCEO of India's Biocon discusses first-quarter resultsPeter Bains, group CEO of the biopharmaceutical company, outlines its growth outlook.
Persons: India's Biocon, Peter Bains
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWe are focused on consolidating our acquired businesses for the coming fiscal year: Biocon BiologicsShreehas Tambe of Biocon Biologics discusses the company's earnings results for the third quarter of fiscal year 2024 following its acquisition of pharmaceutical company Viatris.
Persons: Biocon, Biocon Biologics
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBiocon Biologics is well-placed to take advantage of opportunities in the biosimilars space: CEOShreehas Tambe of Biocon Biologics discusses why he is optimistic about the prospects for the company.
Persons: Shreehas, Biocon Biologics
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailR&D spending: Our pipeline is our 'lifeline,' says Indian biotech firmKiran Mazumdar-Shaw of Biocon discusses the markets with the biggest opportunities for growth.
BENGALURU, Feb 2 (Reuters) - Indian shares are set to open lower on Thursday after a sustained selloff in Adani group stocks as the group cancelled the secondary share sale of its flagship company Adani Enterprises. India's market regulator is said to be examining the crash in the Adani group company shares and looking into possible irregularities in Adani Enterprises' secondary share sale. Indian markets closed lower on Wednesday, hit by Adani group stocks and a fall in insurance companies after the union budget proposed to limit tax exemptions for insurance proceeds. STOCKS TO WATCHBritannia Industries (BRIT.NS): Co posts rise in consolidated net profit in the third quarter on price hikes, sustained demand. Alembic Pharma (ALEM.NS): Co reports consolidated net profit that beat estimates in Q3, on higher domestic sales.
INDIA STOCKS Indian shares may edge higher as inflation eases
  + stars: | 2022-11-15 | by ( ) www.reuters.com   time to read: +2 min
BENGALURU, Nov 15 (Reuters) - Indian shares are expected to open slightly higher on Tuesday, as data showing annual retail inflation eased to a three-month low in October strengthened bets of smaller interest rate hikes from the country's central bank. Globally, investors will get another look at U.S. inflation when the producer price index data is released later in the day. ** Tyremaker Apollo Tyres (APLO.NS) reported a rise in quarterly profit. ** Biocon (BION.NS) reported a decline in quarterly profit as the drugmaker booked a heavy tax expense. ** Indian viscose and chemicals manufacturer Grasim Industries (GRAS.NS) reported a fall in quarterly profit, with brokerage Jefferies saying global slowdown weighed on earnings.
Total: 7